Capital Fund Management (CFM)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Capital Fund Management (CFM)’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,919	Closed	-$696K	–	2128
2019 Q4	$696K	Buy	7,919 +19	+0.2%	+$1.6K	0.01%	1248
2019 Q3	$596K	Buy	7,900 +900	+13%	+$73K	0.01%	1183
2019 Q2	$598K	Buy	+7,000	New	+$692K	0.01%	1162
2015 Q3	–	Sell	-4,051	Closed	-$582K	–	1730
2015 Q2	$582K	Sell	4,051 -1,980	-33%	-$282K	0.01%	1030
2015 Q1	$851K	Sell	6,031 -1,070	-15%	-$165K	0.01%	845
2014 Q4	$1.05M	Buy	+7,101	New	+$1.04M	0.01%	867
2014 Q3	–	Sell	-9,078	Closed	-$1.27M	–	1875
2014 Q2	$1.27M	Buy	+9,078	New	+$1.01M	0.01%	870

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Capital Fund Management (CFM)'s TARO Position: Q1 2020 in Review

Capital Fund Management (CFM) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 7,919 shares — an estimated $696K sold.

Capital Fund Management (CFM) first reported a position in TARO in Q2 2014 and held it in 7 quarters. The position peaked at $1.27M in Q2 2014. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

Capital Fund Management (CFM) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
Capital Fund Management (CFM) sold 7,919 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $696K.
Capital Fund Management (CFM) first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 7 quarters.
Capital Fund Management (CFM)'s Taro Pharmaceutical Industries Ltd. position peaked at $1.27M in Q2 2014.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2020, filed 13 May 2020.